Conversion therapy with tislelizumab for high microsatellite instability, unresectable stage III gastric cancer: a case report

Gastric cancer (GC) is the fifth-highest ranked cancer for incidence and second for mortality from cancer worldwide. Conversion therapy has recently emerged as an alternative therapy for advanced/metastatic GC patients who are unable to undergo surgical resection at the time of diagnosis. Herein, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Jian, Dan, Qian, Chengyuan, Wang, Dong, Ma, Qiang, Wang, Li, Li, Chunxue, Xu, Mingfang, Dai, Nan, Chen, Qian, He, Juan, Zhang, Huan, Yuan, Mingming, Chen, Rongrong, Chao, Rui, Feng, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506721/
https://www.ncbi.nlm.nih.gov/pubmed/34734041
http://dx.doi.org/10.21037/atm-21-4295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506721/
https://www.ncbi.nlm.nih.gov/pubmed/34734041
http://dx.doi.org/10.21037/atm-21-4295

Ejemplares similares